Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Cancer Immunol Res. 2017 Jan 11;5(2):127–136. doi: 10.1158/2326-6066.CIR-16-0293

Table 1.

Adoptive transfer of both CD8+ and CD4+ T cells is required for tumor eradication

Experimental group Treatment Rejection of tumors p value
1 CD8+ (2C) and CD4+ (from CD8−/− B6) T cells 9/9a -
2 CD8+ T cells (2C) only 0/15b P<0.0005d
3 CD4+ T cells (from CD8−/− B6) only 0/4c P=0.001d
a

Data from Fig. 4A–B.

b

Data from Fig. 1B.

c

Data from Fig. 4D.

d

Versus CD8+ and CD4+ T cells.